Medicine Platform
搜索
Product Catagories
首页 > Pharmaceutical Materials > 97% up by HPLC, EP/GMP/DMF Rabeprazole Sodium 117976-90-6
97% up by HPLC, EP/GMP/DMF Rabeprazole Sodium 117976-90-6
单价 面议对比
询价 暂无
发货 全国
过期 长期有效
更新 2025-08-13 23:38
 
详细信息

Grade: Pharmaceutical Grade

Factory Location: Xiamen, Fujian

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East

Monthly Production Capacity: 1000kg

Packaging Information: 25kg/drum 1kg/bottle

Delivery Lead Time: 7 days after payment

Sample Provided: yes

Payment Terms: L/L

 

Product Information

 

Product name

Rabeprazole Sodium

CAS No.

117976-90-6

Molecular Formula

C18H20N3NaO3S

Molecular Weight

381.4245

Quality Standard

97% up by HPLC, EP8/GMP/DMF

Appearance

White powder

 

COA of Rabeprazole Sodium

 

ITEMS

STANDARDS

RESULTS

Appearance

White or slightly yellowish-white hygoscopic powder

Slightly yellowish-white hygoscopic powder

Solubility

Very soluble to freely soluble in water, and freely soluble in anhydrous ethanol, practically insoluble in heptane.

Complies

 

Identification

Infrared absorption spectrum is identical to that of rebeprazole sodium reference standard.

Complies

It gives reaction (a) of sodium

Complies

pH

9.5-11.5

10.5

Related substances

(HPLC)

Impurity A: NMT 0.8%

0.05%

Unspecified impurities: NMT 0.10%

0.09%

Total impurities: NMT 1.0%

0.28%

 

Related substances

(GC)

Methylene chloride: NMT 600ppm

<LOD(LOD=62ppm)

Ethanol: NMT5000ppm

<LOD(LOD=62ppm)

Isopropyl ether: NMT5000ppm

10ppm

Acetone: NMT5000ppm

26ppm

Assay

97.0%-102.0%, calculated on the dried basis

100.6%

Microbial limit

Total aerobic microbial count ≤ 1000cfu/g

< 10cfu/g

Total combined yeasts and molds count ≤ 100cfu/g

< 10cfu/g

Escherichia coli: absence in 1g

Complies

Conclusion

Complies with the requirements of EP8.7

 

Usage

 

Function of Rabeprazole Sodium
 

Rabeprazole is a treatment drug for digestive tract diseases. Its main function is to inhibit the secretion of gastric acid. It is a proton pump inhibitor. This drug has an inhibitory effect on basic gastric acid and the secretion of gastric acid caused by stimulation. It can inhibit the secretion of gastric acid and can also resist Helicobacter pylori. In addition, this drug has no antagonistic effect on choline receptors and histamine receptors. Clinically, rabeprazole is mainly suitable for gastrointestinal diseases such as peptic ulcer and reflux esophagitis.

This drug is relatively safe when used, and there are generally no obvious serious adverse reactions. Patients occasionally see milder side effects such as diarrhea, nausea, fatigue, and dry mouth, which usually disappear after stopping the drug.